BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16365741)

  • 41. Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping.
    Bouzid D; Kammoun A; Amouri A; Mahfoudh N; Haddouk S; Tahri N; Makni H; Masmoudi H
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):482-7. PubMed ID: 22224635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
    Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
    Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA class II allele frequencies in the Lebanese population.
    Khansa S; Hoteit R; Shammaa D; Khalek RA; El Halas H; Greige L; Abbas F; Mahfouz RA
    Gene; 2012 Sep; 506(2):396-9. PubMed ID: 22750800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Normal HLA class I, II, and MICA gene distribution in uveal melanoma.
    Metzelaar-Blok JA; Hurks HM; Naipal A; De Lange P; Keunen JE; Claas FH; Doxiadis II; Jager MJ
    Mol Vis; 2005 Dec; 11():1166-72. PubMed ID: 16379028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Correlation study between ischemic stroke and polymorphism of human leucocyte antigen gene].
    Chen W; Feng H; Xu M; Jia X; Cai L; Xiao L; Liu W
    Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(7):499-502. PubMed ID: 24767290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Family-based association study of HLA class II with type 1 diabetes in Moroccans.
    Drissi Bourhanbour A; Benseffaj N; Ouadghiri S; Razine R; Touzani A; Belafraj A; Essakalli M
    Pathol Biol (Paris); 2015 Apr; 63(2):80-4. PubMed ID: 25555495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of HLA-A, -B, -C, -DR, -DQ polymorphisms in the South Tunisian population and a comparison with other populations.
    Mahfoudh N; Ayadi I; Kamoun A; Ammar R; Mallek B; Maalej L; Hakim F; Gaddour L; Rebai A; Makni H
    Ann Hum Biol; 2013 Jan; 40(1):41-7. PubMed ID: 23095049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sensitivity to bee venom antigen phospholipase A2: association with specific HLA class I and class II alleles and haplotypes in beekeepers and allergic patients.
    Sánchez-Velasco P; Antón E; Muñoz D; Martínez-Quesada J; Ruíz de Alegría C; López-Hoyos M; García-Martín A; Jiménez I; Alonso ST; Duque S; Suárez A; Jerez J; Leyva-Cobián F
    Hum Immunol; 2005 Jul; 66(7):818-25. PubMed ID: 16112029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Using high-resolution human leukocyte antigen typing of 11,423 randomized unrelated individuals to determine allelic varieties, deduce probable human leukocyte antigen haplotypes, and observe linkage disequilibria between human leukocyte antigen-B and-C and human leukocyte antigen-DRB1 and-DQB1 alleles in the Taiwanese Chinese population.
    Yang KL; Chen HB
    Ci Ji Yi Xue Za Zhi; 2017; 29(2):84-90. PubMed ID: 28757772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles.
    De Re V; Caggiari L; Talamini R; Crovatto M; De Vita S; Mazzaro C; Cannizzaro R; Dolcetti R; Boiocchi M
    Hum Immunol; 2004 Nov; 65(11):1397-404. PubMed ID: 15556690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon.
    Gogas H; Kirkwood JM; Falk CS; Dafni U; Sondak VK; Tsoutsos D; Stratigos A; Markopoulos C; Pectasides D; Spyropoulou-Vlachou M
    Cancer; 2010 Sep; 116(18):4326-33. PubMed ID: 20549830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HLA class Ia and Ib molecules and FOXP3+ TILs in relation to the prognosis of malignant melanoma patients.
    Melsted WN; Johansen LL; Lock-Andersen J; Behrendt N; Eriksen JO; Bzorek M; Scheike T; Hviid TVF
    Clin Immunol; 2017 Oct; 183():191-197. PubMed ID: 28882620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Possible association between HLA-DR5 and superficial spreading melanoma (SSM).
    Mueller-Eckhardt G; Schendel DJ; Hundeiker M; Riedel T; O'Neill GJ; Riethmüller G; Mueller-Eckhardt C
    Int J Cancer; 1984 Dec; 34(6):751-5. PubMed ID: 6334654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possible relation between HLA and ABO type and prognosis of uveal melanoma.
    Jager MJ; Völker-Dieben HJ; de Wolff-Rouendaal D; Kakebeeke-Kemme H; D'Amaro J
    Doc Ophthalmol; 1992; 82(1-2):43-7. PubMed ID: 1305026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HLA class I antigens in Japanese patients with melanoma.
    Kageshita T; Naruse T; Hirai S; Horikoshi T; Nakagawa H; Tamaki K; Hayashibe K; Ichihashi M; Nakayama J; Hori Y; Ozawa A; Miyahara M; Ohkido M; Inoko H; Ono T
    J Immunother Emphasis Tumor Immunol; 1996 Nov; 19(6):428-32. PubMed ID: 9041462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HLA variations in patients with diffuse large B-cell lymphoma and association with disease risk and prognosis: a case-control study.
    Diamanti I; Fylaktou A; Verrou E; Vlachaki E; Sinakos M; Katodritou E; Ouranos K; Minti F; Gioula G
    Front Genet; 2024; 15():1341822. PubMed ID: 38680423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ancestry reported by white adults with cutaneous melanoma and control subjects in central Alabama.
    Acton RT; Barton EH; Hollowell WW; Dreibelbis AL; Go RC; Barton JC
    BMC Cancer; 2004 Aug; 4():47. PubMed ID: 15310399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HLA antigens in familial and sporadic cutaneous melanoma.
    Rovini D; Pellegris G; Cascinelli N; Cantoni L; Vaglini M; Placucci M; Santinami M; Belli F; Illeni MT
    Tumori; 1988 Dec; 74(6):657-64. PubMed ID: 3232210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metastatic melanoma to the palatine tonsil with a favourable prognosis.
    Wakasugi S; Kageshita T; Ono T
    Br J Dermatol; 2001 Aug; 145(2):327-9. PubMed ID: 11531803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HLA antigens in malignant melanoma patients.
    Pellegris G; Illeni MT; Vaglini M; Rovini D; Cascinelli N; Masserini C
    Tumori; 1980 Feb; 66(1):51-8. PubMed ID: 6769187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.